WuXi NextCODE’s Shanghai genomic sequencing facility has been accredited by the College of American Pathologists (CAP), becoming the first such lab in China to be licensed by the State of California to process samples. WuXi NextCODE also has CLIA (Clinial Laboratory Improvement Amendments) certification from the US Centers for Medicare and Medicaid (CMS).   “We are a natively global enterprise serving laboratories, hospitals, companies, governments and patients on four continents,”...